Kwong Y. Tsang

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

Benjamin Boyerinas, Caroline Jochéms, Massimo Fantini et al. · Cancer Immunology Research · 2015 · 456 citations · Full text

Life Sciences, Immunology, Oncology +17

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

Sofia R. Gameiro, Momodou L. Jammeh, Max M. Wattenberg et al. · Oncotarget · 2013 · 401 citations · Full text

Medicine, Immunology, Oncology +17

Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune Responses

John L. Marshall, Robert J. Hoyer, Mary Ann Toomey et al. · Journal of Clinical Oncology · 2000 · 357 citations

Medicine, Immunology, Oncology +17

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen et al. · The Lancet Oncology · 2012 · 327 citations · Full text

Medicine, Immunology, Oncology +17

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

Philip M. Arlen, James L. Gulley, Catherine Parker et al. · Clinical Cancer Research · 2006 · 291 citations · Full text

Medicine, Oncology, Pharmacology +17